₹ 365.10
3.10 (0.86%)
B
Biocon
₹ 365.10
Biocon EPS Summary (consolidated)
The latest quarterly EPS of Biocon as of Q2 Sep 2026 stands at ₹0.25. This is a 71.26% fall quarter on quarter and 62.12% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹0.97. It missed the estimate by ₹0.72. For the FY2026 the EPS of Biocon stands at ₹2.82. This is a 66.67% fall compared with FY2025.
Biocon EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

